← Open Payments lookup

EMILY HIMEBAUGH: Open Payments

NPI 1285936617 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,519 in 129 payments from 21 companies in 2025. Trend: 2023 $2,653 · 2024 $2,855 · 2025 $2,519

Food & beverage: $2,519
CompanyPaymentsAmount
ABBVIE INC.36$566
Takeda Pharmaceuticals U.S.A., Inc.11$351
Janssen Biotech, Inc.17$268
Ardelyx, Inc.12$217
Madrigal Pharmaceuticals5$211
Aimmune Therapeutics, Inc.11$170
Gilead Sciences, Inc.4$112
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$110
PFIZER INC.4$81
GENZYME CORPORATION4$77

Products named: ENTYVIO, TREMFYA, IBSRELA, REZDIFFRA, RINVOQ, SKYRIZI, ZENPEP, DUPIXENT.

Industry payments across UT — which companies pay providers there.